SI2170050T1 - Fenilalkilaminski blokatorji kalcijevih kanalov s kratkotrajnim delovanjem in njihova uporaba - Google Patents
Fenilalkilaminski blokatorji kalcijevih kanalov s kratkotrajnim delovanjem in njihova uporabaInfo
- Publication number
- SI2170050T1 SI2170050T1 SI200831291T SI200831291T SI2170050T1 SI 2170050 T1 SI2170050 T1 SI 2170050T1 SI 200831291 T SI200831291 T SI 200831291T SI 200831291 T SI200831291 T SI 200831291T SI 2170050 T1 SI2170050 T1 SI 2170050T1
- Authority
- SI
- Slovenia
- Prior art keywords
- calcium channel
- channel blockers
- short acting
- phenylalkylamine calcium
- acting phenylalkylamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93644007P | 2007-06-20 | 2007-06-20 | |
PCT/US2008/007665 WO2008156820A1 (en) | 2007-06-20 | 2008-06-19 | Short acting phenylalkylamine calcium channel blockers and uses thereof |
EP08768636.6A EP2170050B1 (en) | 2007-06-20 | 2008-06-19 | Short acting phenylalkylamine calcium channel blockers and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2170050T1 true SI2170050T1 (sl) | 2014-12-31 |
Family
ID=40156562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200831291T SI2170050T1 (sl) | 2007-06-20 | 2008-06-19 | Fenilalkilaminski blokatorji kalcijevih kanalov s kratkotrajnim delovanjem in njihova uporaba |
Country Status (19)
Country | Link |
---|---|
US (16) | US20100190852A1 (sl) |
EP (1) | EP2170050B1 (sl) |
JP (1) | JP5421908B2 (sl) |
KR (1) | KR101541557B1 (sl) |
CN (1) | CN101754678B (sl) |
AU (1) | AU2008266798B2 (sl) |
BR (1) | BRPI0812919B8 (sl) |
CA (1) | CA2693627C (sl) |
CY (1) | CY1115619T1 (sl) |
DK (1) | DK2170050T3 (sl) |
ES (1) | ES2498047T3 (sl) |
HK (1) | HK1140913A1 (sl) |
HR (1) | HRP20140801T1 (sl) |
MX (1) | MX347325B (sl) |
NZ (1) | NZ582033A (sl) |
PL (1) | PL2170050T3 (sl) |
PT (1) | PT2170050E (sl) |
SI (1) | SI2170050T1 (sl) |
WO (1) | WO2008156820A1 (sl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2170050T3 (da) | 2007-06-20 | 2014-09-29 | Milestone Pharmaceuticals Inc | Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf |
KR101052620B1 (ko) * | 2008-08-28 | 2011-07-29 | 한국과학기술연구원 | 신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 t-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물 |
KR20120100945A (ko) * | 2009-09-30 | 2012-09-12 | 마이크로도스 테라퓨특스, 인코포레이티드 | 레이노 증후군의 치료를 위한 방법들 및 조성물들 |
EP3068408A4 (en) * | 2013-11-14 | 2017-09-06 | University Medical Pharmaceuticals Corporation | Microneedles for therapeutic agent delivery with improved mechanical properties |
LT3283067T (lt) * | 2015-04-14 | 2020-06-25 | Milestone Pharmaceuticals Inc. | Trumpo poveikio fenilalkilamino kalcio kanalų blokatoriaus gerai vandenyje tipstančios druskos ir jų panaudojimas |
EP4119137A1 (en) * | 2021-07-15 | 2023-01-18 | Milestone Pharmaceuticals Inc. | Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1154810B (de) * | 1961-04-01 | 1963-09-26 | Knoll Ag | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
US3957845A (en) * | 1962-04-27 | 1976-05-18 | Knoll A.G. Chemische Fabriken | Trifluoromethyl-substituted phenyl acetonitriles |
DE1493904A1 (de) * | 1965-07-31 | 1969-06-19 | Knoll Ag | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
DE2059923C3 (de) * | 1970-12-05 | 1979-01-25 | Knoll Ag, 6700 Ludwigshafen | l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel |
JPS5118940B2 (sl) * | 1971-12-25 | 1976-06-14 | ||
DE2631222C3 (de) * | 1976-07-12 | 1979-01-04 | Knoll Ag, 6700 Ludwigshafen | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
DE3144150A1 (de) * | 1981-04-10 | 1982-12-09 | Basf Ag, 6700 Ludwigshafen | (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel |
DE3433383A1 (de) * | 1984-09-12 | 1986-03-20 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue phenyl-acetonitril-derivate |
DE3603032A1 (de) * | 1986-01-31 | 1987-08-06 | Basf Ag | Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel |
US4833162A (en) * | 1988-02-03 | 1989-05-23 | American Cyanamid Company | Substituted benzeneacetonitriles and their use as calcium channel blockers |
IE64870B1 (en) | 1989-12-21 | 1995-09-20 | Searle & Co | Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilators |
US5162569A (en) | 1989-12-21 | 1992-11-10 | G. D. Searle & Co. | Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
US5486539A (en) * | 1989-12-21 | 1996-01-23 | G. D. Searle & Co. | Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
US5247119A (en) * | 1990-12-12 | 1993-09-21 | G. D. Searle & Co. | Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
US6057344A (en) * | 1991-11-26 | 2000-05-02 | Sepracor, Inc. | Methods for treating hypertension, and angina using optically pure (-) amlodipine |
US5451604A (en) * | 1993-07-26 | 1995-09-19 | G. D. Searle & Co. | Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives |
US5910601A (en) * | 1994-09-26 | 1999-06-08 | Darwin Discovery Limited | Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues |
US5859279A (en) | 1996-09-10 | 1999-01-12 | Darwin Discovery Limited | Compound and process |
US6750238B1 (en) | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
US7511077B2 (en) * | 2005-02-09 | 2009-03-31 | Neuromed Pharmaceuticals Ltd. | Diamine calcium channel blockers |
GB2435824A (en) | 2006-03-09 | 2007-09-12 | Esteve Labor Dr | Use of nitrile compounds in the treatment of food related and other disorders |
DK2170050T3 (da) | 2007-06-20 | 2014-09-29 | Milestone Pharmaceuticals Inc | Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf |
-
2008
- 2008-06-19 DK DK08768636.6T patent/DK2170050T3/da active
- 2008-06-19 JP JP2010513245A patent/JP5421908B2/ja active Active
- 2008-06-19 WO PCT/US2008/007665 patent/WO2008156820A1/en active Application Filing
- 2008-06-19 PL PL08768636T patent/PL2170050T3/pl unknown
- 2008-06-19 CA CA2693627A patent/CA2693627C/en active Active
- 2008-06-19 MX MX2009014052A patent/MX347325B/es active IP Right Grant
- 2008-06-19 AU AU2008266798A patent/AU2008266798B2/en active Active
- 2008-06-19 CN CN200880020979.1A patent/CN101754678B/zh active Active
- 2008-06-19 SI SI200831291T patent/SI2170050T1/sl unknown
- 2008-06-19 KR KR1020107000124A patent/KR101541557B1/ko active IP Right Grant
- 2008-06-19 ES ES08768636.6T patent/ES2498047T3/es active Active
- 2008-06-19 PT PT87686366T patent/PT2170050E/pt unknown
- 2008-06-19 US US12/664,026 patent/US20100190852A1/en not_active Abandoned
- 2008-06-19 BR BRPI0812919A patent/BRPI0812919B8/pt active IP Right Grant
- 2008-06-19 NZ NZ582033A patent/NZ582033A/en unknown
- 2008-06-19 EP EP08768636.6A patent/EP2170050B1/en active Active
-
2010
- 2010-08-03 HK HK10107383.8A patent/HK1140913A1/xx unknown
-
2014
- 2014-06-16 US US14/305,626 patent/US9227918B2/en active Active
- 2014-08-22 HR HRP20140801AT patent/HRP20140801T1/hr unknown
- 2014-09-18 CY CY20141100766T patent/CY1115619T1/el unknown
-
2015
- 2015-11-23 US US14/949,107 patent/US9463179B2/en active Active
-
2016
- 2016-09-12 US US15/262,567 patent/US9737503B2/en active Active
-
2017
- 2017-07-18 US US15/653,367 patent/US10010523B2/en active Active
- 2017-07-18 US US15/653,246 patent/US10010522B2/en active Active
- 2017-07-20 US US15/655,564 patent/US10010524B2/en active Active
-
2018
- 2018-06-04 US US15/997,229 patent/US20180280339A1/en not_active Abandoned
-
2019
- 2019-01-14 US US16/246,980 patent/US20190142781A1/en not_active Abandoned
- 2019-08-29 US US16/555,766 patent/US20190380993A1/en not_active Abandoned
-
2020
- 2020-04-09 US US16/844,440 patent/US20200230097A1/en not_active Abandoned
- 2020-11-12 US US17/096,498 patent/US20210059972A1/en not_active Abandoned
-
2021
- 2021-06-22 US US17/354,288 patent/US20210315855A1/en not_active Abandoned
-
2022
- 2022-01-26 US US17/584,686 patent/US20220142963A1/en not_active Abandoned
-
2023
- 2023-04-24 US US18/138,341 patent/US20230255923A1/en not_active Abandoned
- 2023-12-08 US US18/533,381 patent/US20240115543A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2157979A4 (en) | CALCIUM CHANNEL PROTEINS AND USE THEREOF | |
EP2187957A4 (en) | SELECTIVE CYTOPHERESIS DEVICES AND CORRESPONDING METHODS | |
GB2448983B (en) | Permanent anchoring device | |
IL205571A0 (en) | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin | |
EP2303850A4 (en) | NOVEL BLOCKERS OF THE POTASSIUM CHANNEL AND THEIR USES | |
EP2257678A4 (en) | CHANNEL | |
EP2219554A4 (en) | PROGESTER-CONTAINING COMPOSITIONS AND DEVICES | |
EP2330895A4 (en) | SHORT-ACTING BENZOTHIAZEPINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | |
PL2140090T3 (pl) | Urządzenia ograniczające | |
GB0711007D0 (en) | Polymeric microparticles | |
ZA201103456B (en) | Leukolectins and uses thereof | |
EP2291377A4 (en) | IMIDAZOPYRIMIDINONE AND ITS USES | |
HK1140913A1 (en) | Short acting phenylalkylamine calcium channel blockers and uses thereof | |
PL2247601T3 (pl) | Tiazopirymidynony i ich zastosowanie | |
IL204857A0 (en) | Novel aryl potassium channel blockers and uses thereof | |
EP2133326A4 (en) | NEW PSEUDOGLYCOLIPID AND ITS USE | |
GB0703763D0 (en) | Bone-replacement materials,methods and devices | |
EP2375994A4 (en) | STYPTIC DEVICE | |
PL382763A1 (pl) | Śruba kotwiąca | |
EP2323482A4 (en) | SUBSTITUTED DIHYDROISOCHINOLINONE AND ISOCHINOLINDION DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | |
ZA201000357B (en) | 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands | |
TWI368297B (en) | Recessed channel device and method thereof | |
SI2188459T1 (sl) | Žleb za odvodnjavanje | |
HK1146065A1 (en) | Nlrr-1 antagonists and uses thereof nlrr-1 | |
GB0707069D0 (en) | Methods and uses |